In contrast, in our study also GSK461364 treatment of neuroblastoma cells lacking MYCN amplifications and expressing low levels of MYCN significantly inhibited proliferation, induced apoptosis and caused cell cycle arrest in in vitro, and significantly reduced in vivo tumor growth of neuroblastoma cells independent of MYCN copy number status. This evidence concerns the gene MYCN and neuroblastoma.